Literature DB >> 10944199

Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1.

P Henriet1, Z D Zhong, P C Brooks, K I Weinberg, Y A DeClerck.   

Abstract

It is known that the extracellular matrix regulates normal cell proliferation, and it is assumed that anchorage-independent malignant cells escape this regulatory function. Here we demonstrate that human M24met melanoma cells remain responsive to growth regulatory signals that result from contact with type I collagen and that the effect on proliferation depends on the physical structure of the collagen. On polymerized fibrillar collagen, M24met cells are growth arrested at the G(1)/S checkpoint and maintain high levels of p27(KIP1) mRNA and protein. In contrast, on nonfibrillar (denatured) collagen, the cells enter the cell cycle, and p27(KIP1) is down-regulated. These growth regulatory effects involve contact between type I collagen and the collagen-binding integrin alpha(2)beta(1), which appears restricted in the presence of fibrillar collagen. Thus melanoma cells remain sensitive to negative growth regulatory signals originating from fibrillar collagen, and the proteolytic degradation of fibrils is a mechanism allowing tumor cells to escape these restrictive signals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944199      PMCID: PMC27660          DOI: 10.1073/pnas.170290997

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.

Authors:  J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 2.  Cytoskeletal and adhesion proteins as tumor suppressors.

Authors:  A Ben-Ze'ev
Journal:  Curr Opin Cell Biol       Date:  1997-02       Impact factor: 8.382

3.  Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.

Authors:  M Kortylewski; P C Heinrich; A Mackiewicz; U Schniertshauer; U Klingmüller; K Nakajima; T Hirano; F Horn; I Behrmann
Journal:  Oncogene       Date:  1999-06-24       Impact factor: 9.867

4.  Analysis of collagen receptors.

Authors:  S A Santoro; M M Zutter; J E Wu; W D Staatz; E U Saelman; P J Keely
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

5.  Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.

Authors:  E Petitclerc; S Strömblad; T L von Schalscha; F Mitjans; J Piulats; A M Montgomery; D A Cheresh; P C Brooks
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

Review 6.  Regulation of the cdk inhibitor p27 and its deregulation in cancer.

Authors:  J Slingerland; M Pagano
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

7.  Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing.

Authors:  M Shirane; Y Harumiya; N Ishida; A Hirai; C Miyamoto; S Hatakeyama; K Nakayama; M Kitagawa
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

8.  Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.

Authors:  S Takeuchi; H P Koeffler; D R Hinton; I Miyoshi; S Melmed; I Shimon
Journal:  J Endocrinol       Date:  1998-05       Impact factor: 4.286

9.  Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth.

Authors:  S Koop; R Khokha; E E Schmidt; I C MacDonald; V L Morris; A F Chambers; A C Groom
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

10.  E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).

Authors:  B St Croix; C Sheehan; J W Rak; V A Flørenes; J M Slingerland; R S Kerbel
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

View more
  50 in total

1.  Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells.

Authors:  M Kortylewski; P C Heinrich; M E Kauffmann; M Böhm; A MacKiewicz; I Behrmann
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

2.  New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.

Authors:  Meenhard Herlyn; Martin Padarathsingh; Lynda Chin; Mary Hendrix; Dorothea Becker; Mark Nelson; Yves DeClerck; James McCarthy; Suresh Mohla
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 3.  Microenvironmental control of the breast cancer cell cycle.

Authors:  Xun Guo; Yuehan Wu; Helen J Hathaway; Rebecca S Hartley
Journal:  Anat Rec (Hoboken)       Date:  2012-01-24       Impact factor: 2.064

4.  Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells.

Authors:  Yongping Shao; Andrew E Aplin
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

5.  Integration of hyper-compliant microparticles into a 3D melanoma tumor model.

Authors:  Manisha K Shah; Elizabeth A Leary; Eric M Darling
Journal:  J Biomech       Date:  2018-10-25       Impact factor: 2.712

6.  Type I collagen structure regulates cell morphology and EGF signaling in primary rat hepatocytes through cAMP-dependent protein kinase A.

Authors:  John Fassett; Diane Tobolt; Linda K Hansen
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

7.  The stiffness of collagen fibrils influences vascular smooth muscle cell phenotype.

Authors:  Dennis P McDaniel; Gordon A Shaw; John T Elliott; Kiran Bhadriraju; Curt Meuse; Koo-Hyun Chung; Anne L Plant
Journal:  Biophys J       Date:  2006-12-08       Impact factor: 4.033

8.  High doses of laser phototherapy can increase proliferation in melanoma stromal connective tissue.

Authors:  Lúcio Frigo; Joseli Maria Cordeiro; Giovani Marino Favero; Durnavei Augusto Maria; Ernesto Cesar Pinto Leal-Junior; Jon Joensen; Jan Magnus Bjordal; Denise Carvalho Roxo; Rodrigo Labat Marcos; Rodrigo Alvaro Brandão Lopes-Martins
Journal:  Lasers Med Sci       Date:  2018-04-05       Impact factor: 3.161

Review 9.  Environment-mediated drug resistance: a major contributor to minimal residual disease.

Authors:  Mark B Meads; Robert A Gatenby; William S Dalton
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

10.  Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.

Authors:  Jennifer M Roth; Abebe Akalu; Anat Zelmanovich; Desiree Policarpio; Bruce Ng; Shannon MacDonald; Silvia Formenti; Leonard Liebes; Peter C Brooks
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.